Ketamine for pain: An update of uses in palliative care

Journal of Palliative Medicine

Volumn 15, Issue 4, 2012, Pages 474-483

  Prommer, Eric E ^a  

^a MAYO CLINIC HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; CALCIUM; CYTOCHROME P450 3A4; DEXAMETHASONE; DIPYRONE; DOPAMINE; ESKETAMINE; GLYCERYL TRINITRATE; GLYCOPYRRONIUM BROMIDE; HALOPERIDOL; KETAMINE; KETOROLAC; LORAZEPAM; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN; NORKETAMINE; OPIATE; OPIATE RECEPTOR; PLACEBO; SEROTONIN RECEPTOR; TRAMADOL; UNCLASSIFIED DRUG;

ADD ON THERAPY; ANALGESIA; ANOREXIA; BLOOD PRESSURE; CALCIUM TRANSPORT; CANCER PAIN; CHRONIC PAIN; CONTINUOUS INFUSION; CYSTITIS; DELIRIUM; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG METABOLISM; HALLUCINATION; HEART RATE; HUMAN; HYPERSALIVATION; KIDNEY FAILURE; LIVER FAILURE; LUNG VASCULAR RESISTANCE; MEDICAL LITERATURE; NAUSEA; NEUROPATHIC PAIN; PAIN; PALLIATIVE THERAPY; PATIENT MONITORING; PHARMACODYNAMICS; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; STRUCTURE ANALYSIS; SYSTEMIC VASCULAR RESISTANCE; THOUGHT DISORDER; TREATMENT CONTRAINDICATION; ULCERATIVE CYSTITIS; VASCULAR PAIN; VISUAL DISORDER; VIVID DREAM; VOMITING; WORLD HEALTH ORGANIZATION;

ANESTHETICS, DISSOCIATIVE; HUMANS; ISCHEMIA; KETAMINE; NEOPLASMS; NEURALGIA; PAIN; PALLIATIVE CARE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84859796838     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2011.0244     Document Type: Review

References (71)

1. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F: A validation study of the WHO method for cancer pain relief. Cancer 1987;59(4):850-856. (Pubitemid 17018769)
2. Mercadante S: Opioid rotation in cancer pain. Current Pain and Headache Reports 1998;2(3):131-142.
3. Sinner B, Graf BM: Ketamine. Modern Anesthetics 2008; 313-333.
4. Bourke DL, Malit LA, Smith TC: Respiratory interactions of ketamine and morphine. Anesthesiology 1987;66(2):153.
5. Oshima E, Tei K, Kayazawa H, Urabe N: Continuous subcutaneous injection of ketamine for cancer pain. Canadian Journal of Anesthesia/Journal canadien d'anesthhsie 1990;37(3):385-386. (Pubitemid 20139372)
6. Rowland LM: Subanesthetic ketamine: How it alters physiology and behavior in humans. Aviation, space, and environmental medicine 2005;76(7 Suppl):C52.
7. White PF: Clinical pharmacology of intravenous induction drugs. International Anesthesiology Clinics 1988;26(2):98.
8. Johnson RL, Koerner JF: Excitatory amino acid neurotransmission. Journal of Medicinal Chemistry 1988;31(11):2057-2066.
9. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. NEJM 1994; 330(9):613.
10. Mao J: NMDA and opioid receptors: Their interactions in antinociception, tolerance and neuroplasticity. Brain Research Reviews 1999;30(3):289-304. (Pubitemid 29531489)
11. LoTurco JJ, BlantonMG, Kriegstein AR: Initial expression and endogenous activation of NMDA channels in early neocortical development. Journal of Neuroscience 1991;11(3):792.
12. Mayer DJ, Mao J, Price DD: The association of neuropathic pain, morphine tolerance and dependence, and the translocation of protein kinase C. In Discovery of Novel Opioid Medications. 1995; NIDA Research Monograph 147.
13. Mayer ML, Miller RJ: Excitatory amino acid receptors, second messengers and regulation of intracellular Ca2 + in mammalian neurons. Trends in Pharmacological Sciences 1990;11(6):254-260. (Pubitemid 20175421)
14. Schoepp DD, Conn PJ: Metabotropic glutamate receptors in brain function and pathology. Trends in Pharmacological Sciences 1993;14(1):13-20. (Pubitemid 23034602)
15. Haley JE, Dickenson AH, Schachter M: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992;31(3):251-258.
16. Meller ST, Pechman PS, Gebhart GF, Maves TJ: Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 1992;50(1):7-10.
17. Mao J, Price DD, Coghill RC, Mayer DJ, Hayes RL: Spatial patterns of spinal cord [14C]-2-deoxyglucose metabolic activity in a rat model of painful peripheral mononeuropathy. Pain 1992;50(1):89-100.
18. Mao J, Price DD, Phillips LL, Lu J, Mayer DJ: Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Research 1995;677(2):257-267.
19. Kronenberg RH: Ketamine as an analgesic. Journal of Pain & Palliative Care Pharmacotherapy 2002;16(3):27-35.
20. Nishimura M, Sato K: Ketamine stereoselectively inhibits rat dopamine transporter. Neuroscience letters 1999;274(2):131-134. (Pubitemid 29457457)
21. Mikkelsen S, Ilkjaer S, Brennum J, Borgbjerg FM, Dahl JB: The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans. Anesthesiology 1999;90(6):1539.
22. Taylor BJ, Orr SA, Chapman JL, Fisher DE: Beyond-Use Dating of Extemporaneously Compounded Ketamine, Acepromazine, and Xylazine: Safety, Stability, and Efficacy over Time. 2009;48(6):718-726.
23. Kohrs R, Durieux ME: Ketamine: teaching an old drug new tricks. Anesth Analg 1998;87(5):1186-1193. (Pubitemid 28501183)
24. Dickman A, Schneider J, Varga J: The syringe driver: Continuous subcutaneous infusions in palliative care. New York: Oxford University Press; 2005.
25. Kronenberg RH: Ketamine as an Analgesic. Journal of Pain & Palliative Care Pharmacotherapy 2002;16(3):27-35.
26. Schmid RL, Sandler AN, Katz J: Use and efficacy of low-dose ketamine in the management of acute postoperative pain: A review of current techniques and outcomes. Pain 1999;82(2): 111-125. (Pubitemid 29317524)
27. Okon T: Ketamine: An Introduction for a Pain and Palliative Medicine Physician. Pain Physician 2007;10(3):493.
28. Malinovsky JM, Servin F, Cozian A, Lepage JY, Pinaud M: Ketamine and norketamine plasma concentrations after iv, nasal and rectal administration in children. British Journal of Anaesthesia 1996;77(2):203.
29. Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, Green G, Albin R, Hamilton D, Rogers MC, Firestone L, Lavin PT, Mermelstein F: Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: A randomized, double-blind, placebo-controlled, crossover study. Pain 2004;108(1-2):17-27. (Pubitemid 38251669)
30. Yang CY, Wong CS, Chang JY, Ho ST: Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Canadian Journal of Anesthesia/Journal canadien d'anasthesia 1996;43(4):379-383.
31. Mankowitz E, Brock-Utne JG, Cosnett JE, Green-Thompson R: Epidural ketamine: A preliminary report. Survey of Anesthesiology 1983;27(4):229.
32. Ravat F, Dorne R, Baechle JP, Beaulaton A, Lenoir B, Leroy P, Palmier B: Epidural ketamine or morphine for postoperative analgesia. Anesthesiology 1987;66(6):819.
33. Pedraz JL, Calvo MB, Lanao JM, Muriel C, LAMAS JS, Dominguez-Gil A: Pharmacokinetics of rectal ketamine in children. British Journal of Anaesthesia 1989;63(6):671.
34. Azevedo V, Lauretti GR, Pereira NL, Reis MP: Transdermal ketamine as an adjuVant for postoperative analgesia after abdominal gynecological surgery using lidocaine epidural blockade. Anesthesia & Analgesia 2000;91(6):1479.
35. Ben-Ari A, Lewis MC, Davidson E: Chronic administration of ketamine for analgesia. Journal of Pain and Palliative Care Pharmacotherapy 2007;21(1):7-14. (Pubitemid 46607874)
36. Lynch ME, Clark AJ, Sawynok J, SulliVan MJ: Topical amitriptyline and ketamine in neuropathic pain syndromes: An open-label study. The Journal of Pain 2005;6(10):644.
37. Fitzgibbon EJ, Hall P, Schroder C, Seely J, Viola R: Low dose ketamine as an analgesic adjuVant in difficult pain syndromes: A strategy for conversion from parenteral to oral ketamine. Journal of Pain and Symptom Management 2002;23(2):165-170. (Pubitemid 34158651)
38. Koppel C, Arndt I, Ibe K: Effects of enzyme induction, renal and cardiac function on ketamine plasma kinetics in patients with ketamine long-term analgesosedation. Eur J Drug Metab Pharmacokinetics 1990;15:259-263. (Pubitemid 20313127)
39. Thomson IA, Fitch W, Campbell D, Watson R: Effects of ketamine on liver blood flow and hepatic oxygen consumption: Studies in the anaesthetised greyhound. Acta Anaesthesiologica Scandinavica 1988;32(1):10-14. (Pubitemid 18028685)
40. White PF, Way WL, Trevor AJ: Ketamineu its pharmacology and therapeutic uses. Anesthesiology 1982;56(2):119-136. (Pubitemid 12164876)
41. Wolff K, Winstock AR: Ketamine: From medicine to misuse. CNS Drugs 2006;20(3):199-218.
42. Saegusa K, Furukawa Y, Ogiwara Y, Chiba S: Pharmacologic analysis of ketamine-induced cardiac actions in isolated, blood-perfused canine atria. Journal of Cardiovascular Pharmacology 1986;8(2):414.
43. Lundy PM, Lockwood PA, Thompson G, Frew R: Differential effects of ketamine isomers on neuronal and extraneuronal catecholamine uptake mechanisms. Anesthesiology 1986; 64(3):359.
44. Jackson K, Ashby M, Martin P, Pisasale M, Brumley D, Hayes B: Burst ketamine for refractory cancer pain: An openlabel audit of 39 patients. Journal of Pain and Symptom Management 2001;22(4):834-842. (Pubitemid 32884376)
45. Kannan TR, Saxena A, Bhatnagar S, Barry A: Oral ketamine as an adjuVant to oral morphine for neuropathic pain in cancer patients. Journal of Pain and Symptom Management 2002;23(1):60-65. (Pubitemid 34093884)
46. Mildh L, Taittonen M, Leino K, Kirvela O: The effect of lowdose ketamine on fentanyl-induced respiratory depression. Anaesthesia 1998;53(10):965-970. (Pubitemid 28466830)
47. Chu PSK, Ma WK, Wong SCW, Chu RW, Cheng CH, Wong S, Tse JM, Lau FL, Yiu MK, Man CW: The destruction of the lower urinary tract by ketamine abuse: A new syndrome? BJU International 2008;102(11):1616-1622.
48. Mercadante S: Ketamine in cancer pain: an update. Palliative Medicine 1996;10(3):225.
49. Mayberg TS, Lam AM, Matta BF, Domino KB, Winn HR: Ketamine does not increase cerebral blood flow velocity or intracranial pressure during isoflurane/nitrous oxide anesthesia in patients undergoing craniotomy. Anesthesia & Analgesia 1995;81(1):84.
50. Irwin SA, Iglewicz A: Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care. J Palliat Med 2010;13(7):903-908.
51. Khandrani J, Rajput A, Dahake S, Verma N: Ketamine induced seizures. The Internet Journal of Anesthesiology 2009;19(1).
52. Abend NS, Dlugos DJ: Treatment of refractory status epilepticus: Literature review and a proposed protocol. Pediatric Neurology 2008;38(6):377-390. (Pubitemid 351671983)
53. Mercadante S, Arcuri E, Tirelli W, Casuccio A: Analgesic effect of intravenous ketamine in cancer patients on morphine Therapy: A randomized, controlled, double-blind, crossover, double-dose study. Journal of Pain and Symptom Management 2000;20(4):246-252.
54. Lauretti GR, Lima ICPR, Reis MP, Prado WA, Pereira NL: Oral ketamine and transdermal nitroglycerin as analgesic adjuVants to oral morphine therapy for cancer pain management. Anesthesiology 1999;90(6):1528.
55. Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S: Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. Journal of Pain and Symptom Management 2005;30(5):485-491. (Pubitemid 41718968)
56. Mitchell AC, Fallon MT: A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: Results of a double blind randomised controlled trial. Pain 2002;97(3):275-281. (Pubitemid 34607223)
57. Sigtermans MJ, Van Hilten JJ, Bauer MCR, Arbous MS, Marinus J, Sarton EY, Dahan A: Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 2009;145(3):304-311.
58. Eide PK, Jørum E, Stubhaug A, Bremnes J, Breivik H: Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994;58(3):347-354. (Pubitemid 24284077)
59. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M: Response of chronic neuropathic pain syndromes to ketamine: A preliminary study. Pain 1994;56(1):51-57. (Pubitemid 24037259)
60. Lynch ME, Clark AJ, Sawynok J: A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. The Clinical Journal of Pain 2003;19(5):323.
61. Lynch ME, Clark AJ, Sawynok J, SulliVan MJL: Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial. Anesthesiology 2005;103(1):140.
62. Lockhart E: Topical analgesics: Topical combination of amitriptyline and ketamine for post herpetic neuralgia. The Journal of Pain 2004;5(3):S82.
63. Finch PM, Knudsen L, Drummond PD: Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine. Pain 2009;146(1-2):18-25.
64. Cohen SP, Chang AS, Larkin T, Mao J: The intravenous ketamine test: A predictive response tool for oral dextromethorphan treatment in neuropathic pain. Anesthesia & Analgesia 2004;99(6):1753.
65. Luczak J, Dickenson AH, Kotlinska-Lemieszek A: The role of ketamine, an NMDA receptor antagonist, in the management of pain. Progress in Palliative Care 1995;3(4):127-134.
66. Kotlinska-Lemieszek A, Luczak J. Subanesthetic ketamine: An essential adjuVant for intractable cancer pain. Journal of Pain and Symptom Management 2004;28(2):100-102. (Pubitemid 38970071)
67. Benitez-Rosario MA, Salinas-Martin A, Gonzalez-Guillermo T, Feria M: A strategy for conversion from subcutaneous to oral ketamine in cancer pain patients: Effect of a 1:1 ratio. Journal of Pain and Symptom Management. In press.
68. Kannan TR, Saxena A, Bhatnagar S, Barry A: Oral ketamine as an adjuVant to oral morphine for neuropathic pain in cancer patients. Journal of Pain and Symptom Management 2002;23(1):60-65. (Pubitemid 34093884)
69. Jackson K, Ashby M, Howell D, Petersen J, Brumley D, Good P, Pisasale M, Wein S, Woodruff R: The effectiveness and adverse effects profile of "burst" ketamine in refractory cancer pain: The VCOG PM 1-00 study. J Palliat Care 2010; 26(3):176-183.
70. Fitzgibbon EJ, Viola R: Parenteral ketamine as an analgesic adjuVant for severe pain: Development and retrospective audit of a protocol for a palliative care unit. J Palliat Med 2005;8(1):49-57. (Pubitemid 40144251)
71. KetamineDrugstore.com (last accessed June 2011).